Zobrazeno 1 - 10
of 13
pro vyhledávání: '"B J Auerbach"'
Publikováno v:
Journal of Lipid Research, Vol 38, Iss 12, Pp 2502-2515 (1997)
Low density lipoprotein (LDL) reduction independent of LDL receptor regulation was investigated using HMG-CoA reductase inhibitors in LDL receptor-deficient mice. In males, LDL cholesterol dose-dependently decreased with atorvastatin treatment after
Externí odkaz:
https://doaj.org/article/7134225cd4744b8bb794c59eb39272fd
Autor:
M E Pape, B C Barnett, Todd Leff, A D Essenburg, B J Auerbach, Sabine Haubenwallner, L L Minton, R B DeMattos, B R Krause, Roger S. Newton
Publikováno v:
Journal of Lipid Research, Vol 36, Iss 12, Pp 2541-2551 (1995)
For the last 30 years fibrates have been widely prescribed to treat human dyslipidemia. However, the primary mechanism by which they lower plasma lipid levels is still unknown. Studies with transgenic mice have suggested that changes in apoC-III expr
Publikováno v:
Journal of Lipid Research, Vol 31, Iss 4, Pp 738-742 (1990)
A rapid and inexpensive micro-assay for determining cholesterol in plasma and isolated lipoprotein fractions has been established which utilizes a commercially available enzymatic reagent with semi-automated instruments and microtiter plates. The ass
Autor:
B R, Krause, B J, Auerbach
Publikováno v:
Current opinion in investigational drugs (London, England : 2000). 2(3)
The apparent protective effect of high density lipoprotein cholesterol (HDL) with respect to coronary heart disease (CHD) is generally thought to reside in its ability to transport cholesterol from peripheral cells to the liver for excretion from the
Autor:
C L, Bisgaier, A D, Essenburg, B C, Barnett, B J, Auerbach, S, Haubenwallner, T, Leff, A D, White, P, Creger, M E, Pape, T J, Rea, R S, Newton
Publikováno v:
Journal of lipid research. 39(1)
In the current studies we describe the effects of PD 72953 and related compounds on lipoprotein levels in chow-fed male rats. After 2 weeks, 10 mg/kg of PD 72953 daily was as effective as 100 mg/kg gemfibrozil for elevating HDL-cholesterol. At 100 mg
Autor:
C L, Bisgaier, A D, Essenburg, B J, Auerbach, M E, Pape, C S, Sekerke, A, Gee, S, Wölle, R S, Newton
Publikováno v:
Journal of lipid research. 38(12)
Low density lipoprotein (LDL) reduction independent of LDL receptor regulation was investigated using HMG-CoA reductase inhibitors in LDL receptor-deficient mice. In males, LDL cholesterol dose-dependently decreased with atorvastatin treatment after
Autor:
S, Haubenwallner, A D, Essenburg, B C, Barnett, M E, Pape, R B, DeMattos, B R, Krause, L L, Minton, B J, Auerbach, R S, Newton, T, Leff
Publikováno v:
Journal of lipid research. 36(12)
For the last 30 years fibrates have been widely prescribed to treat human dyslipidemia. However, the primary mechanism by which they lower plasma lipid levels is still unknown. Studies with transgenic mice have suggested that changes in apoC-III expr
Publikováno v:
The Journal of clinical endocrinology and metabolism. 70(6)
Toward the definition of optimal postmenopausal estrogen replacement we compared the effects of three graduated doses of two oral estrogens, estrone sulfate and 17 beta-estradiol, on the lipid profiles of two groups of six postmenopausal women. Becau
Autor:
B J Auerbach, John S. Parks
Publikováno v:
Journal of Biological Chemistry. 264:10264-10270
Density gradient ultracentrifugation was used to isolate and characterize the plasma lipoproteins from African green monkeys before and 24 and 48 h after subcutaneous injection of 300 µg/kg lipopolysaccharide (LPS) to induce an acute phase response.
Autor:
B J, Auerbach, J S, Parks
Publikováno v:
The Journal of biological chemistry. 264(17)
Density gradient ultracentrifugation was used to isolate and characterize the plasma lipoproteins from African green monkeys before and 24 and 48 h after subcutaneous injection of 300 micrograms/kg lipopolysaccharide (LPS) to induce an acute phase re